Ufp Technologies (UFPT) Capital Expenditures Growth (3y) (2013 - 2025)
Ufp Technologies (UFPT) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 9.52% |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn | -25.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -64.51% |
| Jun 30, 2025 | -22.63% |
| Mar 31, 2025 | 6.47% |
| Sep 30, 2024 | -48.81% |
| Jun 30, 2024 | 14.77% |
| Mar 31, 2024 | 6.13% |
| Dec 31, 2023 | -99.16% |
| Sep 30, 2023 | 45.37% |
| Jun 30, 2023 | 34.83% |
| Mar 31, 2023 | 28.79% |
| Dec 31, 2022 | 28.50% |
| Sep 30, 2022 | 14.00% |
| Jun 30, 2022 | 62.74% |
| Mar 31, 2022 | 18.92% |
| Dec 31, 2021 | 7.22% |
| Sep 30, 2021 | -13.36% |
| Jun 30, 2021 | 6.98% |
| Mar 31, 2021 | -1.01% |
| Dec 31, 2020 | -27.93% |
| Sep 30, 2020 | -27.82% |